-
1 Comment
Trevena, Inc is currently in a long term downtrend where the price is trading 26.3% below its 200 day moving average.
From a valuation standpoint, the stock is 94.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 73.6.
Trevena, Inc's total revenue rose by 122.6% to $69K since the same quarter in the previous year.
Its net income has dropped by 84.2% to $-12M since the same quarter in the previous year.
Finally, its free cash flow fell by 5.2% to $-7M since the same quarter in the previous year.
Based on the above factors, Trevena, Inc gets an overall score of 2/5.
Exchange | F |
---|---|
CurrencyCode | EUR |
ISIN | None |
Sector | |
Industry |
Market Cap | 1M |
---|---|
PE Ratio | None |
Target Price | 5.33 |
Dividend Yield | 0.0% |
Beta | 1.86 |
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV027 for the treatment of acute lung injury contributing to acute respiratory distress syndrome and abnormal blood clotting in patients with COVID-19; TRV250, a G protein biased delta-opioid receptor agonist for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. The company has a collaboration with Imperial College London to evaluate Trv027 in Covid-19 patients. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 6T4.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025